Mesenchymal Stem Cell-Derived Exosomes: The New Frontier for the Treatment of Intervertebral Disc Degeneration
Low back pain (LBP) is one of the most frequent symptoms associated with intervertebral disc degeneration (IDD) and affects more than 80% of the population, with strong psychosocial and economic impacts. The main cause of IDD is a reduction in the proteoglycan content within the nucleus pulposus (NP...
Main Authors: | Veronica Tilotta, Gianluca Vadalà, Luca Ambrosio, Fabrizio Russo, Claudia Cicione, Giuseppina Di Giacomo, Rocco Papalia, Vincenzo Denaro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/11/23/11222 |
Similar Items
-
Wharton's Jelly mesenchymal stromal cell‐derived extracellular vesicles promote nucleus pulposus cell anabolism in an in vitro 3D alginate‐bead culture model
by: Veronica Tilotta, et al.
Published: (2024-03-01) -
Mesenchymal stem cell-derived secretome enhances nucleus pulposus cell metabolism and modulates extracellular matrix gene expression in vitro
by: Veronica Tilotta, et al.
Published: (2023-03-01) -
Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration
by: Zhichao Li, et al.
Published: (2022-09-01) -
Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration
by: Zoe Krut, et al.
Published: (2021-08-01) -
Exosomes derived from human urine–derived stem cells ameliorate IL-1β-induced intervertebral disk degeneration
by: Guang Qian, et al.
Published: (2024-07-01)